What is included in this Sample?
- * Market Segmentation
- * Key Findings
- * Research Scope
- * Table of Content
- * Report Structure
- * Report Methodology
Download FREE Sample Report
Microbiome Therapeutics Market Size, Share, Growth, and Industry Analysis, By Type (Upper GIT,Lower GIT), By Application (C. difficile Infection (CDI),Inflammatory Bowel Disease (IBD),Orphan Drug,Immuno-oncology,Others), Regional Insights and Forecast to 2035
Last Updated: 09 April 2026
|
Base Year:
2025
|
Historical Data:
2021-2024
|
No of Pages:
159
Region:
Global
|
Format:
PDF
|
Report ID:
BRI128048
|
SKU ID: 29537211
- Scope of the Report
- Market Introduction
- Years Considered
- Research Objectives
- Market Research Methodology
- Research Process and Data Source
- Economic Indicators
- Currency Considered
- Market Estimation Caveats
- Executive Summary
- World Market Overview
- Global Microbiome Therapeutics Market Size (2020-2031)
- Microbiome Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
- World Current & Future Analysis for Microbiome Therapeutics by Country/Region (2020, 2024 & 2031)
- Microbiome Therapeutics Segment by Type
- Upper GIT
- Lower GIT
- Microbiome Therapeutics Market Size by Type
- Microbiome Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
- Global Microbiome Therapeutics Market Size Market Share by Type (2020-2025)
- Microbiome Therapeutics Segment by Application
- C. difficile Infection (CDI)
- Inflammatory Bowel Disease (IBD)
- Orphan Drug
- Immuno-oncology
- Others
- Microbiome Therapeutics Market Size by Application
- Microbiome Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
- Global Microbiome Therapeutics Market Size Market Share by Application (2020-2025)
- World Market Overview
- Microbiome Therapeutics Market Size by Player
- Microbiome Therapeutics Market Size Market Share by Player
- Global Microbiome Therapeutics Revenue by Player (2020-2025)
- Global Microbiome Therapeutics Revenue Market Share by Player (2020-2025)
- Global Microbiome Therapeutics Key Players Head office and Products Offered
- Market Concentration Rate Analysis
- Competition Landscape Analysis
- Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
- New Products and Potential Entrants
- Mergers & Acquisitions, Expansion
- Microbiome Therapeutics Market Size Market Share by Player
- Microbiome Therapeutics by Region
- Microbiome Therapeutics Market Size by Region (2020-2025)
- Global Microbiome Therapeutics Annual Revenue by Country/Region (2020-2025)
- Americas Microbiome Therapeutics Market Size Growth (2020-2025)
- APAC Microbiome Therapeutics Market Size Growth (2020-2025)
- Europe Microbiome Therapeutics Market Size Growth (2020-2025)
- Middle East & Africa Microbiome Therapeutics Market Size Growth (2020-2025)
- Americas
- Americas Microbiome Therapeutics Market Size by Country (2020-2025)
- Americas Microbiome Therapeutics Market Size by Type (2020-2025)
- Americas Microbiome Therapeutics Market Size by Application (2020-2025)
- United States
- Canada
- Mexico
- Brazil
- APAC
- APAC Microbiome Therapeutics Market Size by Region (2020-2025)
- APAC Microbiome Therapeutics Market Size by Type (2020-2025)
- APAC Microbiome Therapeutics Market Size by Application (2020-2025)
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Europe
- Europe Microbiome Therapeutics Market Size by Country (2020-2025)
- Europe Microbiome Therapeutics Market Size by Type (2020-2025)
- Europe Microbiome Therapeutics Market Size by Application (2020-2025)
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Middle East & Africa Microbiome Therapeutics by Region (2020-2025)
- Middle East & Africa Microbiome Therapeutics Market Size by Type (2020-2025)
- Middle East & Africa Microbiome Therapeutics Market Size by Application (2020-2025)
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Market Drivers, Challenges and Trends
- Market Drivers & Growth Opportunities
- Market Challenges & Risks
- Industry Trends
- Global Microbiome Therapeutics Market Forecast
- Global Microbiome Therapeutics Forecast by Region (2026-2031)
- Global Microbiome Therapeutics Forecast by Region (2026-2031)
- Americas Microbiome Therapeutics Forecast
- APAC Microbiome Therapeutics Forecast
- Europe Microbiome Therapeutics Forecast
- Middle East & Africa Microbiome Therapeutics Forecast
- Americas Microbiome Therapeutics Forecast by Country (2026-2031)
- United States Market Microbiome Therapeutics Forecast
- Canada Market Microbiome Therapeutics Forecast
- Mexico Market Microbiome Therapeutics Forecast
- Brazil Market Microbiome Therapeutics Forecast
- APAC Microbiome Therapeutics Forecast by Region (2026-2031)
- China Microbiome Therapeutics Market Forecast
- Japan Market Microbiome Therapeutics Forecast
- Korea Market Microbiome Therapeutics Forecast
- Southeast Asia Market Microbiome Therapeutics Forecast
- India Market Microbiome Therapeutics Forecast
- Australia Market Microbiome Therapeutics Forecast
- Europe Microbiome Therapeutics Forecast by Country (2026-2031)
- Germany Market Microbiome Therapeutics Forecast
- France Market Microbiome Therapeutics Forecast
- UK Market Microbiome Therapeutics Forecast
- Italy Market Microbiome Therapeutics Forecast
- Russia Market Microbiome Therapeutics Forecast
- Middle East & Africa Microbiome Therapeutics Forecast by Region (2026-2031)
- Egypt Market Microbiome Therapeutics Forecast
- South Africa Market Microbiome Therapeutics Forecast
- Israel Market Microbiome Therapeutics Forecast
- Turkey Market Microbiome Therapeutics Forecast
- Global Microbiome Therapeutics Forecast by Type (2026-2031)
- Global Microbiome Therapeutics Forecast by Application (2026-2031)
- GCC Countries Market Microbiome Therapeutics Forecast
- Global Microbiome Therapeutics Forecast by Region (2026-2031)
- Key Players Analysis
- Seres Therapeutics
- Seres Therapeutics Company Information
- Seres Therapeutics Microbiome Therapeutics Product Offered
- Seres Therapeutics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- Seres Therapeutics Main Business Overview
- Seres Therapeutics Latest Developments
- Assembly Biosciences
- Assembly Biosciences Company Information
- Assembly Biosciences Microbiome Therapeutics Product Offered
- Assembly Biosciences Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- Assembly Biosciences Main Business Overview
- Assembly Biosciences Latest Developments
- Synthetic Biologics
- Synthetic Biologics Company Information
- Synthetic Biologics Microbiome Therapeutics Product Offered
- Synthetic Biologics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- Synthetic Biologics Main Business Overview
- Synthetic Biologics Latest Developments
- Interxon
- Interxon Company Information
- Interxon Microbiome Therapeutics Product Offered
- Interxon Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- Interxon Main Business Overview
- Interxon Latest Developments
- PureTech
- PureTech Company Information
- PureTech Microbiome Therapeutics Product Offered
- PureTech Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- PureTech Main Business Overview
- PureTech Latest Developments
- Synlogic
- Synlogic Company Information
- Synlogic Microbiome Therapeutics Product Offered
- Synlogic Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- Synlogic Main Business Overview
- Synlogic Latest Developments
- Enterome BioScience
- Enterome BioScience Company Information
- Enterome BioScience Microbiome Therapeutics Product Offered
- Enterome BioScience Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- Enterome BioScience Main Business Overview
- Enterome BioScience Latest Developments
- 4D Pharma
- 4D Pharma Company Information
- 4D Pharma Microbiome Therapeutics Product Offered
- 4D Pharma Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 4D Pharma Main Business Overview
- 4D Pharma Latest Developments
- Second Genome
- Second Genome Company Information
- Second Genome Microbiome Therapeutics Product Offered
- Second Genome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- Second Genome Main Business Overview
- Second Genome Latest Developments
- AOBiome
- AOBiome Company Information
- AOBiome Microbiome Therapeutics Product Offered
- AOBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- AOBiome Main Business Overview
- AOBiome Latest Developments
- C3 Jian
- C3 Jian Company Information
- C3 Jian Microbiome Therapeutics Product Offered
- C3 Jian Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- C3 Jian Main Business Overview
- C3 Jian Latest Developments
- Rebiotix
- Rebiotix Company Information
- Rebiotix Microbiome Therapeutics Product Offered
- Rebiotix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- Rebiotix Main Business Overview
- Rebiotix Latest Developments
- MicroBiome Therapeutics LLC
- MicroBiome Therapeutics LLC Company Information
- MicroBiome Therapeutics LLC Microbiome Therapeutics Product Offered
- MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- MicroBiome Therapeutics LLC Main Business Overview
- MicroBiome Therapeutics LLC Latest Developments
- Metabiomics
- Metabiomics Company Information
- Metabiomics Microbiome Therapeutics Product Offered
- Metabiomics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- Metabiomics Main Business Overview
- Metabiomics Latest Developments
- Ritter Pharmaceuticals
- Ritter Pharmaceuticals Company Information
- Ritter Pharmaceuticals Microbiome Therapeutics Product Offered
- Ritter Pharmaceuticals Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- Ritter Pharmaceuticals Main Business Overview
- Ritter Pharmaceuticals Latest Developments
- Symberix
- Symberix Company Information
- Symberix Microbiome Therapeutics Product Offered
- Symberix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- Symberix Main Business Overview
- Symberix Latest Developments
- OpenBiome
- OpenBiome Company Information
- OpenBiome Microbiome Therapeutics Product Offered
- OpenBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- OpenBiome Main Business Overview
- OpenBiome Latest Developments
- Azitra
- Azitra Company Information
- Azitra Microbiome Therapeutics Product Offered
- Azitra Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- Azitra Main Business Overview
- Azitra Latest Developments
- Symbiotix Biotherapies
- Symbiotix Biotherapies Company Information
- Symbiotix Biotherapies Microbiome Therapeutics Product Offered
- Symbiotix Biotherapies Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- Symbiotix Biotherapies Main Business Overview
- Symbiotix Biotherapies Latest Developments
- Osel
- Osel Company Information
- Osel Microbiome Therapeutics Product Offered
- Osel Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- Osel Main Business Overview
- Osel Latest Developments
- Metabogen
- Metabogen Company Information
- Metabogen Microbiome Therapeutics Product Offered
- Metabogen Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- Metabogen Main Business Overview
- Metabogen Latest Developments
- Seres Therapeutics
- Research Findings and Conclusion